⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Neurovascular Interface in Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-28 — Is amyloid beta peptide a driver of inflammaging?: cross-connection with amyloid-beta-inflammaging: Aβ clearance depends on perivascular and BBB routes that fail with neurovascular-interface aging, linking Aβ-driven neuroinflammaging to the heart–brain NVI framework. (novelty: 3)
- 2026-09-12 — Soluble pathogenic tau transmission to astrocytes drives acute oxidative damage, cellular senescence, and neurovascular uncoupling in a model of Alzheimers tauopathy: cross-connection with cellular-senescence: Tau-triggered astrocyte senescence and SASP produce impaired neurovascular coupling in a tauopathy model, linking glial senescence biology to the neurovascular-interface aging framework. (novelty: 3)
- 2026-09-21 — Plasma inflammatory markers and brain white matter microstructure in late middle-aged and older adults.: cross-connection with inflammaging: Peripheral pro-inflammatory markers (including GFAP) associate with white-matter microstructure independent of AD biomarkers, providing human imaging evidence that systemic inflammaging tone registers at the neurovascular/white-matter interface. (novelty: 3)
- 2026-09-16 — Cross-organ crosstalk in brain-aging-related sarcopenia: Caudate iron accumulation impairs muscle health via blood-brain barrier dysfunction.: cross-connection with brain-muscle-axis: The finding operationalizes the neurovascular interface as a mediator of peripheral (muscle) aging rather than only cognitive endpoints, expanding the NVI framework beyond cardio-cerebrovascular comorbidity. (novelty: 3)
- 2026-06-01 — Adipose tissue as a systemic modulator of brain aging: mechanistic links between metabolism, inflammation and neurodegeneration.: cross-connection with adipose-brain-aging-axis: Adipose-derived inflammatory and metabolic signals are proposed as an upstream peripheral input to the aged heart–brain neurovascular interface, extending the NVI framework beyond cardiac-origin drivers. (novelty: 3)
- 2026-09-11 — Dendritic Cell Antigen Presentation Enables T Cells to Enter the Brain and Contribute to Tau Pathology: cross-connection with immunosenescence: Dendritic-cell-licensed T-cell brain entry links peripheral adaptive-immune aging to the aged neurovascular interface as a joint substrate for tau pathology. (novelty: 3)
- 2026-07-13 — Nanoparticles as an efficient strategy to eliminate senescent brain endothelial cells.: cross-connection with cellular-senescence: Targeted senolysis of senescent brain endothelial cells restored BBB integrity in aged rats, operationalizing the cellular-senescence → neurovascular-interface link with a delivery-vehicle refinement of an established senolytic. (novelty: 3)
- 2026-08-24 — Bridging structure and function: triple network remodeling driven by white matter hyperintensities in vascular cognitive impairment.: cross-connection with vascular-aging: White matter hyperintensities as a vascular-aging substrate driving large-scale functional network disruption operationalizes the neurovascular-interface framework at the level of specific cognitive networks. (novelty: 3)
- 2026-08-03 — Aging at the neurovascular interface: An integrative framework linking cardiovascular and cerebrovascular diseases.: 2026 conceptual review formalizes the neurovascular interface (NVI) as a shared aging substrate across heart and brain, integrating vascular, neural, inflammatory, and ECM changes modified by genetic susceptibility, and nominates lifestyle, senolytics, and gene-guided precision medicine as candidate levers — narrative synthesis, no new primary data. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
Aging at the neurovascular interface: An integrative framework linking cardiovascular and cerebrovascular diseases.
03-aug-2026
novelty 3
per-area 3
strengthens